Kazia Therapeutics LTD (KZIA) SEC Filings — 2025

Filings

• Kazia Therapeutics Files 6-K on Staff Determination Letter — 6-K · Dec 19, 2025
• Kazia Therapeutics Presents Paxalisib Data — 6-K · Dec 10, 2025
• Kazia Therapeutics LTD 6-K Filing — 6-K · Dec 5, 2025
• Kazia Therapeutics LTD 6-K Filing — 6-K · Dec 2, 2025
• Kazia Therapeutics LTD 6-K Filing — 6-K · Nov 18, 2025
• Kazia's Losses Mount to A$134.8M Amidst Plummeting Licensing Revenue — 20-F · Nov 7, 2025
• Kazia Therapeutics Files October 2025 6-K Report — 6-K · Oct 7, 2025
• Kazia Therapeutics Files 6-K Report — 6-K · Oct 2, 2025
• Kazia Therapeutics Files September 2025 6-K Report — 6-K · Sep 11, 2025
• Kazia Therapeutics Announces Private Placement — 6-K · Aug 1, 2025
• Kazia Therapeutics Files Form 6-K — 6-K · Jul 25, 2025
• Kazia Therapeutics Files Form 6-K — 6-K · Jul 9, 2025
• Kazia Therapeutics Files Form 6-K — 6-K · Jun 11, 2025
• Kazia Therapeutics Files 6-K with Financial Updates — 6-K · Jun 10, 2025
• Kazia Therapeutics Files Form 6-K — 6-K · Jun 5, 2025
• Kazia Therapeutics Files May 2025 6-K Report — 6-K · May 28, 2025
• Kazia Therapeutics Files 6-K, Formerly Novogen Ltd — 6-K · May 15, 2025
• Kazia Therapeutics to change ADS to Ordinary Share ratio — 6-K · Apr 15, 2025
• Kazia Therapeutics Files March 2025 6-K Report — 6-K · Mar 31, 2025
• Kazia Therapeutics Files 2024 Annual Report — 6-K · Mar 13, 2025
• Kazia Therapeutics Files 6-K Report — 6-K · Feb 20, 2025
• Kazia Therapeutics Files 6-K Report — 6-K · Feb 3, 2025
• Kazia Therapeutics Files January 2025 6-K Report — 6-K · Jan 30, 2025
• Kazia Therapeutics Announces Registered Direct Offering — 6-K · Jan 13, 2025